Latest Microparticles Stories
Researchers have made an important step towards creating medical nanorobots.
Today most medicines are produced biotechnologically.
Xtalks presents an exciting live webinar on Tuesday October 29, 2013 at 11:00am EDT on current strategies for maximizing efficiency in the drug development process. Toronto,
Before scientists and engineers can realize the dream of using stem cells to create replacements for worn out organs and battle damaged body parts, they'll have to develop ways to grow complex three-dimensional structures in large volumes and at costs that won't bankrupt health care systems.
ASU bioengineering research produces design for new device to help detect diseases quickly and at lower costs.
Researchers at Emory University and the Georgia Institute of Technology have developed microscopic polymer beads that can deliver an antioxidant enzyme made naturally by the body into the heart.
STOCKHOLM, Sweden, August 20 /PRNewswire/ -- XSpray Microparticles AB, a life science technology company, today announced the launch of its new GMP production facility in Malmo, Sweden.
STOCKHOLM, April 27 /PRNewswire/ -- Xspray Microparticles AB, the Swedish life science technology company, has developed a cutting-edge solution for pharmaceutical particle production based on supercritical fluid technology. The Company's RightSize Particle Manufacturing Technology overcomes many of the drawbacks of traditional micronization and is well suited to demanding applications.
New advances result in accurate ID of smaller particles using holograms
Remote controlled with a magnetic field, aggregates of plastic particles on a microchip function like stirrers and pumps.
- Growing in low tufty patches.